Key Takeaways
- HGS BioScience, backed by Paine Schwartz Partners, has acquired NutriAg Ltd., a Toronto-based developer of bionutritional technologies.
- The acquisition combines HGS’s U.S. presence and expertise in humic and fulvic acid products with NutriAg’s bionutritional innovations and Canadian market reach.
- The unified company will offer a broader product range across humics, fulvics, amino acids, carbohydrate chelation, plant extracts, and microbial technologies.
- Proprietary technologies such as NutriAg’s PolyAldoCarbosate® (PAC) platform and HGS’s HumiK ONE and GrowPlex brands will anchor the joint innovation pipeline.
- The move strengthens HGS BioScience’s position as one of North America’s most comprehensive biostimulant and bionutritional providers.
HGS BioScience Expands Through Acquisition of NutriAg
HGS BioScience, a leader in humic and fulvic-based agricultural inputs, announced the acquisition of NutriAg Ltd., a Canadian firm known for its bionutritional research and product development. The deal combines two complementary portfolios, forming a stronger platform to serve retailers and farmers across the United States, Canada, and international markets.
According to the company, the integration of HGS BioScience’s vertically integrated manufacturing and distribution capabilities with NutriAg’s R&D expertise will create one of the most complete product offerings in the growing biostimulant and bionutritional sectors.
Strengthening Innovation and Market Reach
The combined company will leverage both organizations’ proprietary technologies to deliver enhanced solutions for plant health and soil productivity. NutriAg’s PAC platform, which focuses on carbohydrate chelation, will complement HGS BioScience’s core product lines, HumiK ONE and GrowPlex, to offer a broader range of biological and nutritional formulations.
“The biostimulant and bionutritional spaces are among the fastest-growing in agriculture — but they are fragmented and often confusing for retailers,” said Mike Steffeck, CEO of HGS BioScience. “By bringing HGS and NutriAg together, we can provide one of the most robust product platforms in the market, delivering greater ROI and yield stability for farmers.”
Martin Bloomberg, President and CEO of NutriAg, added that the merger provides new growth opportunities: “Our combined capabilities make us the partner of choice for retailers and farmers. Retailers gain one trusted source for an extensive portfolio, while farmers benefit from field-tested products that drive resilience and profitability.”
HGS & NutriAg: A Consolidated Platform for Biostimulant Growth
The acquisition supports HGS BioScience’s strategy to expand its leadership in sustainable crop inputs through:
- An expanded portfolio spanning humic and fulvic acids, bionutritionals, and microbial technologies.
- Broader geographic access across the U.S., Canada, and key global markets.
- A stronger innovation pipeline uniting research platforms from both companies.
As part of Paine Schwartz Partners’ agtech investment portfolio, HGS BioScience continues to build scale and capability in the biological inputs market — aligning its research, production, and distribution assets to meet growing demand for sustainable agricultural solutions.
